Giiant Pharma Inc.
$345,000.00
National Research Council Canada | Conseil national de recherches Canada
Industrial Research Assistance Program – Contributions to Firms
EF 2021-2022
Canada
Giiant Pharma develops new therapeutic for the gastrointestinal tract. The project aims to finalize the preclinical development and the production process to position the product for clinical trials.